Uterine serous carcinoma

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Uterine serous carcinoma | |
|---|---|
| Micrograph of uterine serous carcinoma | |
| Synonyms | Uterine papillary serous carcinoma |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Abnormal uterine bleeding, pelvic pain, weight loss |
| Complications | Metastasis, ascites |
| Onset | Typically postmenopausal |
| Duration | Chronic |
| Types | Endometrial cancer |
| Causes | Genetic mutations, obesity, hormonal imbalances |
| Risks | Age, family history, Lynch syndrome |
| Diagnosis | Endometrial biopsy, imaging studies |
| Differential diagnosis | Endometrioid carcinoma, clear cell carcinoma |
| Prevention | Regular screening, healthy lifestyle |
| Treatment | Surgery, chemotherapy, radiation therapy |
| Medication | Chemotherapeutic agents, hormonal therapy |
| Prognosis | Variable, depends on stage and response to treatment |
| Frequency | Less common than endometrioid carcinoma |
| Deaths | Significant mortality if advanced |
Uterine serous carcinoma is a type of endometrial cancer that is characterized by its aggressive nature and poor prognosis. It is a subtype of endometrial carcinoma and is distinct from the more common endometrioid carcinoma.
Pathophysiology[edit]
Uterine serous carcinoma arises from the endometrium, the lining of the uterus. Unlike endometrioid carcinoma, which is often associated with estrogen exposure, uterine serous carcinoma is not typically linked to hormonal factors. It is thought to develop from endometrial intraepithelial carcinoma (EIC), a precursor lesion.
Clinical Presentation[edit]
Patients with uterine serous carcinoma often present with postmenopausal vaginal bleeding. Due to its aggressive nature, the cancer may have already spread beyond the uterus at the time of diagnosis. Other symptoms may include pelvic pain and ascites.
Diagnosis[edit]
Diagnosis is typically made through a combination of endometrial biopsy, imaging studies, and histopathological examination. On microscopic examination, uterine serous carcinoma is characterized by papillary structures and high-grade nuclear atypia.
Treatment[edit]
The treatment of uterine serous carcinoma often involves a combination of surgery, chemotherapy, and radiation therapy. Surgical management usually includes a hysterectomy with bilateral salpingo-oophorectomy and staging procedures. Due to the high risk of recurrence, adjuvant chemotherapy and radiation therapy are commonly employed.
Prognosis[edit]
The prognosis for uterine serous carcinoma is generally poor compared to other types of endometrial cancer. This is due to its aggressive nature and tendency to present at an advanced stage. The five-year survival rate is significantly lower than that for endometrioid carcinoma.